COMMITTED TO QUALITY
Type:
Administration Route :
Cancer Site:
Act luvica

Act Louvika

Ibrutinib

Category:

Chemical

Oral

, ,

Dosage form :

Capsules

Doses :

140 mg
Act Louvika contains the active substance ibrutinib. Act Louvika is an antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia.

Bratoma

Temozolomide

Category:

Chemical

Oral

Dosage form :

Capsules

Doses :

5/20/100/140/250 mg
Bratoma contains a medicine called temozolomide. This medicine is an antitumor agent. Bratoma is used for the treatment of specific forms of brain tumors.

Carboxa

Carboplatin

Category:

Chemical

Injectable

Dosage form :

Vials

Doses :

50/150/450 mg
Carboxa contains the active substance carboplatin. Carboxa is a medicine that is used to treat cancer of the ovaries. It acts by interfering with the division of rapidly multiplying cells, particularly cancer cells.

Dotixa

Dasatinib

Category:

Chemical

Oral

,

Dosage form :

Tablets

Doses :

70/100 mg
Dotixa contains the active substance dasatinib. Dotixa is used to treat Philadelphia chromosome positive (pH+) Chronic Lymphoblastic Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) in adults, adolescents, and children at least 1 year of age who are not benefiting from prior therapies.

Enlido

Lenalidomide

Category:

Chemical

Oral

, ,

Dosage form :

Capsules

Doses :

10/15/25 mg
Enlido contains the active substance "lenalidomide". This medicine belongs to a group of medicines which affect how your immune system works
Evacim actero pharma

Evacim

Bevacizumab

Category:

Biologic

Injectable

, , , , ,

Dosage form :

Vials

Doses :

100/400 mg
Evacim contains the active substance bevacizumab, which is a humanised monoclonal antibody. Evacim binds selectively to a protein called human vascular endothelial growth factor (VEGF), which is found on the lining of blood and lymph vessels in the body. The VEGF protein causes blood vessels to grow within tumours, these blood vessels provide the tumour with nutrients and oxygen. Once bevacizumab is bound to VEGF, tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and oxygen to the tumour.

Evrolia

Everolimus

Category:

Chemical

Oral

Dosage form :

Tablets

Doses :

5/10 mg
Evrolia is an anticancer medicine containing the active substance everolimus. Evrolia reduces the blood supply to the tumour and slows down the growth and spread of cancer cells.

Fracta

Zoledronic Acid

Category:

Chemical

Injectable

,

Dosage form :

Vials

Doses :

4mg
The active substance in Fracta is zoledronic acid, which belongs to a group of substances called bisphosphonates. Fracta works by attaching itself to the bone and slowing down the rate of bone change.

Ibract

Palbociclib

Category:

Chemical

Oral

Dosage form :

Capsules

Doses :

75/100/125 mg
Ibract is an anticancer medicine containing the active substance palbociclib. Palbociclib works by blocking proteins called cyclin-dependent kinase 4 and 6, which regulate cell growth and division. Blocking these proteins can slow down growth of cancer cells and delay the progression of cancer.

Imatinib ACTe

Imatinib

Category:

Chemical

Oral

, , ,

Dosage form :

Tablets

Doses :

100/400 mg
Imatinib ACTe is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinases are proteins that cells use to signal to each other to grow.